2016
DOI: 10.1089/bfm.2016.0023
|View full text |Cite
|
Sign up to set email alerts
|

Breastmilk-Derived Mesenchymal Stem Cells In Vitro Are Likely to Be Mediated Through Epithelial–Mesenchymal Transition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
6

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 7 publications
0
2
0
6
Order By: Relevance
“…In a comprehensive report that compared various stem cell types for their potential efficacy to sequester stroke-induced neuroinflammation, feasibility as translational clinical cell sources, safety and suitability as a transplantable material, hBmSCs have been suggested as a promising source of stem cells for treatment of a stroke-associated pathology [ 72 ]. This concept for the potential therapeutic benefit of hBmSCs is largely based on results of in vitro studies where hBmSCs were cultured and differentiated in vitro followed by identification of the growth factors that they secreted [ 73 , 74 ]. Of particular importance for stroke therapy is the ability of certain subpopulations of these differentiated cells to produce VEGF and HGF and a protocol for culturing breast milk-derived cells that increase production of these factors has been established [ 73 ].…”
Section: Potential Therapeutic Use Of Breast Milk-derived Cellsmentioning
confidence: 99%
“…In a comprehensive report that compared various stem cell types for their potential efficacy to sequester stroke-induced neuroinflammation, feasibility as translational clinical cell sources, safety and suitability as a transplantable material, hBmSCs have been suggested as a promising source of stem cells for treatment of a stroke-associated pathology [ 72 ]. This concept for the potential therapeutic benefit of hBmSCs is largely based on results of in vitro studies where hBmSCs were cultured and differentiated in vitro followed by identification of the growth factors that they secreted [ 73 , 74 ]. Of particular importance for stroke therapy is the ability of certain subpopulations of these differentiated cells to produce VEGF and HGF and a protocol for culturing breast milk-derived cells that increase production of these factors has been established [ 73 ].…”
Section: Potential Therapeutic Use Of Breast Milk-derived Cellsmentioning
confidence: 99%
“…Growth factors are also secreted by breast milk stem cells (180). In fact, the concept for the potential therapeutic benefit of human milk stem cells (HMSCs) is largely based on the results of studies where HMSCs were cultured and differentiated in vitro followed by identification of the growth factors that they secreted (291,292). For example, of particular importance for stroke therapy is the ability of certain subpopulations of these differentiated cells to produce VEGF and HGF and a protocol for culturing breast milk-derived cells that increase the production of these factors, which has been established (293).…”
Section: Multi-organ Damagementioning
confidence: 99%
“…Грудное молоко формирует защиту сосудов и способствует развитию детского сердца, поскольку содержит семейство факторов роста [3,4], включая эпидермальный фактор роста (EGF), фактор роста сосудистого эндотелия (VEGF), фактор роста гепатоцитов (HGF), инсулиноподобные факторы роста [5,6], которые, действуя через аутокринные или паракринные механизмы, инициируют клеточный рост, становление дифференцированной функции. Установлено, что фактор роста гепатоцитов (HGF) способствует дифференцировке стволовых клеток сердца [7].…”
unclassified
“…Epidermal growth factor (EGF), в изобилии определяющийся в молоке кормящих матерей независимо от продолжительности беременности, имеет более высокую концентрацию в переходном грудном молоке женщин, родивших детей с очень низкой и экстремально низкой массой тела по сравнению с женщинами, родившими доношенных детей [8]. Фактор роста сосудистого эндотелия особенно важен и полезен для ранних стадий васкулогенеза и ангиогенеза у недоношенных детей [5,9], что весьма существенно, поскольку изменения васкулогенеза и ангиогенеза, выявленные у недоношенных детей еще в эмбриональной жизни, продолжаются и в зрелом возрасте [10].…”
unclassified
See 1 more Smart Citation